<SEC-DOCUMENT>0001193125-18-303701.txt : 20181022
<SEC-HEADER>0001193125-18-303701.hdr.sgml : 20181022
<ACCEPTANCE-DATETIME>20181022090911
ACCESSION NUMBER:		0001193125-18-303701
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20181022
FILED AS OF DATE:		20181022
DATE AS OF CHANGE:		20181022

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			DBV Technologies S.A.
		CENTRAL INDEX KEY:			0001613780
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			I0
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36697
		FILM NUMBER:		181131640

	BUSINESS ADDRESS:	
		STREET 1:		177-181 AVENUE PIERRE BROSSOLETTE
		CITY:			MONTROUGE
		STATE:			I0
		ZIP:			92120
		BUSINESS PHONE:		33(0)155427878

	MAIL ADDRESS:	
		STREET 1:		177-181 AVENUE PIERRE BROSSOLETTE
		CITY:			MONTROUGE
		STATE:			I0
		ZIP:			92120
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>d520258d6k.htm
<DESCRIPTION>6-K
<TEXT>
<HTML><HEAD>
<TITLE>6-K</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES&nbsp;AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>FORM <FONT
STYLE="white-space:nowrap">6-K</FONT> </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>REPORT OF
FOREIGN PRIVATE ISSUER </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>PURSUANT TO RULE <FONT STYLE="white-space:nowrap">13a-16</FONT> OR
<FONT STYLE="white-space:nowrap">15d-16</FONT> </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>UNDER THE SECURITIES EXCHANGE ACT OF 1934 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>For the Month of October 2018 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Commission File Number: <FONT STYLE="white-space:nowrap">001-36697</FONT> </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>DBV TECHNOLOGIES S.A. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Translation of registrant&#146;s name into English) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><FONT
STYLE="white-space:nowrap">177-181</FONT> avenue Pierre Brossolette </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>92120 Montrouge France </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Address of principal executive office) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether
the registrant files or will file annual reports under cover of Form <FONT STYLE="white-space:nowrap">20-F</FONT> or Form <FONT STYLE="white-space:nowrap">40-F:</FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT STYLE="white-space:nowrap">&#9746;&nbsp;&nbsp;Form&nbsp;20-F&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&#9744;&nbsp;&nbsp;Form</FONT> <FONT STYLE="white-space:nowrap">40-F</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark if the registrant is submitting the Form <FONT
STYLE="white-space:nowrap">6-K</FONT> in paper as permitted by Regulation <FONT STYLE="white-space:nowrap">S-T</FONT> Rule 101(b)(1):&nbsp;&nbsp;&#9744; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark if the registrant is submitting the Form <FONT STYLE="white-space:nowrap">6-K</FONT> in paper as permitted by Regulation <FONT
STYLE="white-space:nowrap">S-T</FONT> Rule 101(b)(7):&nbsp;&nbsp;&#9744; </P> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>EXHIBIT LIST </U></B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD WIDTH="92%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Exhibit</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Description</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Press Release dated October&nbsp;22, 2018.</TD></TR>
</TABLE>
</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SIGNATURES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned,
thereunto duly authorized. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="45%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="44%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>DBV TECHNOLOGIES S.A.</B></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Date: October&nbsp;22, 2018</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ David Schilansky</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">David Schilansky</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Deputy Chief Executive Officer</TD></TR>
</TABLE>
</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g520258g98l48.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>DBV Technologies Announces Submission of Biologics License Application for Viaskin Peanut to the U.S. Food and Drug
Administration </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">DBV Technologies (Euronext: DB - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT) today announced the submission of a Biologics License
Application (BLA) to the U.S. Food and Drug Administration (FDA) for Viaskin Peanut for the treatment of peanut allergy in children four to 11 years of age. Viaskin Peanut is the Company&#146;s lead product candidate, which is based on epicutaneous
immunotherapy (EPIT), a proprietary technology platform that delivers biologically active compounds to the immune system through the skin. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>&#147;This
submission represents a significant step forward for those families living with peanut allergy. We are thankful for the patients, investigators and DBV employees&#146; efforts in making this milestone possible,&#148;</I> said
<B>Dr.</B><B></B><B>&nbsp;Pierre-Henri Benhamou</B>, Chairman&nbsp;&amp; Chief Executive Officer of DBV Technologies. <I>&#147;We have been developing Viaskin Peanut for over 10 years, with over 1,000 patients studied in our clinical trials, and we
are excited about the possibility of helping patients suffering from peanut allergy.&#148;</I> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Viaskin Peanut previously received Breakthrough and Fast
Track Designation from the FDA in 2015 and 2012, respectively. The BLA for Viaskin Peanut is supported by a global development program comprised of seven clinical trials. Data from Phase III studies, PEPITES and REALISE, which studied patients four
to 11 years of age for 12 months, as well as supportive long-term data from the Company&#146;s open-label Phase II program, were included in this submission. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Dr.</B><B></B><B>&nbsp;Hugh Sampson</B>, Chief Scientific Officer of DBV Technologies and Kurt Hirschhorn Professor of Pediatrics at the Icahn School of
Medicine at Mount Sinai said, <I>&#147;</I><I>We </I><I>believe that the safety and efficacy data generated in our clinical trials support our mission to potentially offer EPIT, a proprietary desensitization treatment, to peanut-allergic children in
an easy and convenient manner for families.</I><I>&#148;</I> </P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g520258g16i16.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About DBV Technologies</B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">DBV Technologies is developing Viaskin&reg;, a proprietary technology platform with broad potential applications in immunotherapy. Viaskin is based on
epicutaneous immunotherapy, or EPIT&reg;, DBV&#146;s method of delivering biologically active compounds to the immune system through intact skin. With this new class of self-administered and <FONT STYLE="white-space:nowrap">non-invasive</FONT>
product candidates, the Company is dedicated to safely transforming the care of food allergic patients, for whom there are no approved treatments. DBV&#146;s food allergies programs include ongoing clinical trials of Viaskin Peanut and Viaskin Milk,
and preclinical development of Viaskin Egg. DBV is also pursuing a human <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">proof-of-concept</FONT></FONT> clinical study of Viaskin Milk for the treatment of Eosinophilic Esophagitis,
and exploring potential applications of its platform in vaccines and other immune diseases. DBV Technologies has global headquarters in Montrouge, France and New York, NY. The Company&#146;s ordinary shares are traded on segment A of Euronext Paris
(Ticker: DBV, ISIN code: FR0010417345), part of the SBF120 index, and the Company&#146;s ADSs (each representing <FONT STYLE="white-space:nowrap">one-half</FONT> of one ordinary share) are traded on the Nasdaq Global Select Market (Ticker: DBVT).
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward Looking Statements </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This press release may
contain forward-looking statements and estimates, including statements regarding the potential of Viaskin Peanut and Company&#146;s regulatory plans regarding Viaskin Peanut. These forward-looking statements and estimates are not promises or
guarantees and involve substantial risks and uncertainties. At this stage, the products of the Company have not been authorized for sale in any country. Among the factors that could cause actual results to differ materially from those described or
projected herein include uncertainties associated generally with related regulatory reviews and approvals and clinical trials. A further list and description of these risks, uncertainties and other risks can be found in the Company&#146;s regulatory
filings with the French Autorit&eacute; des March&eacute;s Financiers, the Company&#146;s Securities and Exchange Commission filings and reports, including in the Company&#146;s Annual Report on Form <FONT STYLE="white-space:nowrap">20-F</FONT> for
the year ended December&nbsp;31, 2017 and future filings and reports by the Company. Existing and prospective investors are cautioned not to place undue reliance on these forward-looking statements and estimates, which speak only as of the date
hereof. Other than as required by applicable law, DBV Technologies undertakes no obligation to update or revise the information contained in this Press Release. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>DBV Investor Relations Contact </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Sara Blum Sherman </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Senior Director, Investor Relations&nbsp;&amp; Strategy </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">+1&nbsp;212-271-0740</FONT></FONT> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U><FONT STYLE="white-space:nowrap">sara.sherman@dbv-technologies.com</FONT> </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>DBV Media Contact </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Joe Becker </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">VP, Global Corporate Communications </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">+1&nbsp;646-650-3912</FONT></FONT> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U><FONT STYLE="white-space:nowrap">joseph.becker@dbv-technologies.com</FONT> </U></B></P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g520258g16i16.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g520258g16i16.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M_P"%'*',']O:G_S\_P#D-?\ "CE#F#^WM3_Y^?\ R&O^%'*',']O:G_S\_\
MD-?\*.4.8/[>U/\ Y^?_ "&O^%'*',']O:G_ ,_/_D-?\*.4.8/[>U/_ )^?
M_(:_X4<H<P?V]J?_ #\_^0U_PHY0Y@_M[4_^?G_R&O\ A1RAS!_;VI_\_/\
MY#7_  HY0Y@_M[4_^?G_ ,AK_A1RAS!_;VI_\_/_ )#7_"CE#F#^WM3_ .?G
M_P AK_A1RAS!_;VI_P#/S_Y#7_"CE#F#^WM3_P"?G_R&O^%'*',']O:G_P _
M/_D-?\*.4.8/[>U/_GY_\AK_ (4<H<P?V]J?_/S_ .0U_P *.4.8/[>U/_GY
M_P#(:_X4<H<P?V]J?_/S_P"0U_PHY0Y@_M[4_P#GY_\ (:_X4<H<P?V]J?\
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@!#0!VVG_\ (,M?^N2?R% '(7G_ "$+G_KHW\S2B,AIB84 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % "&D!
MVVG_ /(,M?\ KDG\A0!R%Y_R$+G_ *Z-_,T1&0TQ,* "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M/_X#'_&C^T*G_/IA_9U#_GZ@_P"%4ZU_<G_\!C_C1_:%3_GTP_LZA_S]0?\
M"J=:_N3_ /@,?\:/[0J?\^F']G4/^?J#_A5.M?W)_P#P&/\ C1_:%3_GTP_L
MZA_S]0?\*IUK^Y/_ . Q_P :/[0J?\^F']G4/^?J#_A5.M?W)_\ P&/^-']H
M5/\ GTP_LZA_S]0?\*IUK^Y/_P" Q_QH_M"I_P ^F']G4/\ GZ@_X53K7]R?
M_P !C_C1_:%3_GTP_LZA_P _4'_"J=:_N3_^ Q_QH_M"I_SZ8?V=0_Y^H/\
MA5.M?W)__ 8_XT?VA4_Y],/[.H?\_4'_  JG6O[D_P#X#'_&C^T*G_/IA_9U
M#_GZ@_X53K7]R?\ \!C_ (T?VA4_Y],/[.H?\_4'_"J=:_N3_P#@,?\ &C^T
M*G_/IA_9U#_GZ@_X53K7]R?_ ,!C_C1_:%3_ )],/[.H?\_4'_"J=:_N3_\
M@,?\:/[0J?\ /IA_9U#_ )^H/^%4ZU_<G_\  8_XT?VA4_Y],/[.H?\ /U!_
MPJG6O[D__@,?\:/[0J?\^F']G4/^?J#_ (53K7]R?_P&/^-']H5/^?3#^SJ'
M_/U!_P *IUK^Y/\ ^ Q_QH_M"I_SZ8?V=0_Y^H/^%4ZU_<G_ / 8_P"-']H5
M/^?3#^SJ'_/U!_PJG6O[D_\ X#'_ !H_M"I_SZ8?V=0_Y^H/^%4ZU_<G_P#
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M/_X#'_&C^T*G_/IA_9U#_GZ@_P"%4ZU_<G_\!C_C1_:%3_GTP_LZA_S]0?\
M"J=:_N3_ /@,?\:/[0J?\^F']G4/^?J#_A5.M?W)_P#P&/\ C1_:%3_GTP_L
MZA_S]0?\*IUK^Y/_ . Q_P :/[0J?\^F']G4/^?J#_A5.M?W)_\ P&/^-']H
M5/\ GTP_LZA_S]0?\*IUK^Y/_P" Q_QH_M"I_P ^F']G4/\ GZ@_X53K7]R?
M_P !C_C1_:%3_GTP_LZA_P _4'_"J=:_N3_^ Q_QH_M"I_SZ8?V=0_Y^H/\
MA5.M?W)__ 8_XT?VA4_Y],/[.H?\_4'_  JG6O[D_P#X#'_&C^T*G_/IA_9U
M#_GZ@_X53K7]R?\ \!C_ (T?VA4_Y],/[.H?\_4'_"J=:_N3_P#@,?\ &C^T
M*G_/IA_9U#_GZ@_X53K7]R?_ ,!C_C1_:%3_ )],/[.H?\_4'_"J=:_N3_\
M@,?\:/[0J?\ /IA_9U#_ )^H/^%4ZU_<G_\  8_XT?VA4_Y],/[.H?\ /U!_
MPJG6O[D__@,?\:/[0J?\^F']G4/^?J#_ (53K7]R?_P&/^-']H5/^?3#^SJ'
M_/U!_P *IUK^Y/\ ^ Q_QH_M"I_SZ8?V=0_Y^H/^%4ZU_<G_ / 8_P"-']H5
M/^?3#^SJ'_/U!_PJG6O[D_\ X#'_ !H_M"I_SZ8?V=0_Y^H/^%4ZU_<G_P#
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !2 *8!0 E%P%H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0!D:K<RRSIIEH^R>4;F?^XOK5Q2W9+?0A
M\[["ZZ7I<(>X49=WZ+[D]S36NK#R0X: \QWWFH7$C'J$;:H^E'/;9!RL!H<U
ML?,LM0F5EZ)(=RGZTN9/="Y6AFY-662QOHA!>QC*D?\ H2FG\.J%OH6M)NI'
M$MG<G-Q;':3_ 'AV-3-=4.+TLS4J2PH * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H 2@##T^52VHZF_)#% >VU16LE:T3-/J6="@V:>
ML[Y,LY,CD]>>E1/5E174T\5)0N*5@,?781'#%J*9$MJP(/JI/(-:1UT)>FI%
M=/Y>NZ;<Q\+.IC;'0\9%4E>+1+U:9NUD:!0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 T],4 <Q:ACX1O /O!G!_,5M+XC-?"=!8$
M&PMBO3RU_E6<MRX[%FI&% %#6R!HMWG_ )YFJCN3+8S)@5@T)3]_>G\JT74G
ML=$.E8F@4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M-_>;5O:?9V8_:)I,C_EH^<5DW?H=$86ZLM5)H% !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 (>E &+K6A#4&CN[:3[/J$',4P_D?45M3J.&CU1R
M5\.I^]'1HH6E_'KL,FE:G&;34HCG;TSZ,O\ A3E'D]^.J%2K>T]RII(L-=HR
M_P!GZW%CTFQA6]#GL:CSB;W[D\6GW,* :?JI\KLKJ' ^AI-]T4EV8DVGR2J?
M[3U0F'NB@1@_6FG;X4)KN1"[-TGV#2(O+@ VO.5X4>WJ:+6UD/?1%.XOGMW3
M0="&^Z(_>W!Y6+U)]ZUC&_OS.&K6?-[*EN^O8U]%T.#1X#M/FW,OS33-U<UE
M4FY^ATT:"I+S-4"LSH"@!: "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * $XS0!D:#K]IXBLY[FR254@G>W82J =RGG&">*;7*+
M=%70-<T?Q:M\UM:%OL5PUO)Y\2\L.N.3Q5N4X;,CV=.6\4;L5M;P?ZJ"./\
MW5 J7*3W8*E".JBB3 ]*DT%Q0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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MU*'NQOW!ZRL>F+Q61H+0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 5M1LTU#3+JRD.$N(FB8^S C^M"=M1,\S^''B*'PS:/X.\2S+8:C92
M,(3,VU)8V.00QXZDUK-.7O(A22=F=3XC\=Z/H5BYANX;S4'&+>T@?>\C'H,+
MDX]ZF,&V4VEH8_P<,Q\'71N5VSG4)C(#V;Y<_KFJK?$3#8Y#X=>*X/#FOZ];
M:JWV;3+N_E,=T^=BR@G*D]LJ0?PK2<6TK"B[,]1U'QKX:TJQ:ZN-:L_+"[@$
MF5V;Z ')K!4Y-E\R1S?PML=0GEUSQ/JENT$VKSAX5?J(AG;]!SC\*TJM+W4*
M.]R]\4=):Z\,?VM:@C4='D6[MW4<C:1N'TQS^%33>O*$T4_A7I\]Q87_ (KO
ME OM<F,I Z+&"0H'MU_#%%31V0H*QZ)69H% !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M(_L\2D1*A543H,<8[=*-6!<SCM0 ;N.E,8M( H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
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M3!?VQAED8N VX[PKGEE&%YR>2>?1BN5SJ42Z3B+5;F3Q/D$6CSON\W.2GE9
MV=1TQCG/>@+EZ6\@6]U"+5]3O+6]:4BUBCD=/DP-IC4<29/)R&YX]J+=D%S!
MM=4UZ31(WM;F>25M,M'DDD!+*&E<228_O!.>.>*=D%S8TZ[%P]ZUKX@B-LMF
M_F-#++<+$QQM?<S$*1SP#S^&:5@N;7A2]%[ILS*Z2".8QB6.Y:>.3 !RK-SC
MG!'8@U,E9E)F_4C"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H 0T
M-*+YH;:-W3..: !U5F7<H..1D=* '4 & .U ".H9"& (]#0 * %  P .E #-
MB^9NVC=TSCF@#D-?0P^([*VBFGCAO^;A$F<!CD#C!^7CTQ6D1'6VEK!96L5K
M;1+%!"H2-%Z*H' K,9(BJB$*H49Z 8H <JJB[5  '84 +0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
,!0 4 % !0 4 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g520258g98l48.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g520258g98l48.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M\*.4.8/[>U/_ )^?_(:_X4<H<P?V]J?_ #\_^0U_PHY0Y@_M[4_^?G_R&O\
MA1RAS!_;VI_\_/\ Y#7_  HY0Y@_M[4_^?G_ ,AK_A1RAS!_;VI_\_/_ )#7
M_"CE#F#^WM3_ .?G_P AK_A1RAS!_;VI_P#/S_Y#7_"CE#F#^WM3_P"?G_R&
MO^%'*',']O:G_P _/_D-?\*.4.8/[>U/_GY_\AK_ (4<H<P?V]J?_/S_ .0U
M_P *.4.8/[>U/_GY_P#(:_X4<H<P?V]J?_/S_P"0U_PHY0Y@_M[4_P#GY_\
M(:_X4<H<P?V]J?\ S\_^0U_PHY0Y@_M[4_\ GY_\AK_A1RAS!_;VI_\ /S_Y
M#7_"CE#F#^WM3_Y^?_(:_P"%'*',']O:G_S\_P#D-?\ "CE#F#^WM3_Y^?\
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MY_\ (:_X4<H<P?V]J?\ S\_^0U_PHY0Y@_M[4_\ GY_\AK_A1RAS!_;VI_\
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 -?[C?
M2A[#2._K(=C@V^^?J:T)$I@% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 U_N-]*'L-'?UF4<&WWS]35D"4P"@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H :_P!Q
MOI0]AH[^LRC@W/SGZFM"!N: #- !F@ S0 9H ,T &: #- !F@ S0 9H ,T &
M: #- !F@ S0 9H ,T &: #- !F@ S0 9H ,T &: #- !F@ S0 9H ,T &: #
M- !F@ S0 9H ,T &: #- !F@ S0 9H ,T &: #- !F@ S0 9H ,T &: #- !
MF@ S0 9H ,T &: #- !F@ S0 9H ,T &: #- !F@ S0 9H ,T &: #- !F@
MS0 9H ,T &: #- !F@ S0 9H ,T &: #- !F@ S0 9H ,T &: #- !F@ S0
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MX_YA_P *ET#_ )YI_P!^4_PH]C4_G?X?Y!];A_S[C^/^8?\ "I= _P">:?\
M?E/\*/8U/YW^'^0?6X?\^X_C_F'_  J70/\ GFG_ 'Y3_"CV-3^=_A_D'UN'
M_/N/X_YA_P *ET#_ )YI_P!^4_PH]C4_G?X?Y!];A_S[C^/^8?\ "I= _P">
M:?\ ?E/\*/8U/YW^'^0?6X?\^X_C_F'_  J70/\ GFG_ 'Y3_"CV-3^=_A_D
M'UN'_/N/X_YA_P *ET#_ )YI_P!^4_PH]C4_G?X?Y!];A_S[C^/^8?\ "I=
M_P">:?\ ?E/\*/8U/YW^'^0?6X?\^X_C_F'_  J70/\ GFG_ 'Y3_"CV-3^=
M_A_D'UN'_/N/X_YA_P *ET#_ )YI_P!^4_PH]C4_G?X?Y!];A_S[C^/^8?\
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MA_S[C^/^8?\ "I= _P">:?\ ?E/\*/8U/YW^'^0?6X?\^X_C_F'_  J70/\
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MX_YA_P *ET#_ )YI_P!^4_PH]C4_G?X?Y!];A_S[C^/^8?\ "I= _P">:?\
M?E/\*/8U/YW^'^0?6X?\^X_C_F'_  J70/\ GFG_ 'Y3_"CV-3^=_A_D'UN'
M_/N/X_YA_P *ET#_ )YI_P!^4_PH]C4_G?X?Y!];A_S[C^/^8?\ "I= _P">
M:?\ ?E/\*/8U/YW^'^0?6X?\^X_C_F'_  J70/\ GFG_ 'Y3_"CV-3^=_A_D
M'UN'_/N/X_YA_P *ET#_ )YI_P!^4_PH]C4_G?X?Y!];A_S[C^/^8?\ "I=
M_P">:?\ ?E/\*/8U/YW^'^0?6X?\^X_C_F'_  J70/\ GFG_ 'Y3_"CV-3^=
M_A_D'UN'_/N/X_YA_P *ET#_ )YI_P!^4_PH]C4_G?X?Y!];A_S[C^/^8?\
M"I= _P">:?\ ?E/\*/8U/YW^'^0?6X?\^X_C_F'_  J70/\ GFG_ 'Y3_"CV
M-3^=_A_D'UN'_/N/X_YA_P *ET#_ )YI_P!^4_PH]C4_G?X?Y!];A_S[C^/^
M8?\ "I= _P">:?\ ?E/\*/8U/YW^'^0?6X?\^X_C_F'_  J70/\ GFG_ 'Y3
M_"CV-3^=_A_D'UN'_/N/X_YA_P *ET#_ )YI_P!^4_PH]C4_G?X?Y!];A_S[
MC^/^8?\ "I= _P">:?\ ?E/\*/8U/YW^'^0?6X?\^X_C_F'_  J70/\ GFG_
M 'Y3_"CV-3^=_A_D'UN'_/N/X_YA_P *ET#_ )YI_P!^4_PH]C4_G?X?Y!];
MA_S[C^/^8?\ "I= _P">:?\ ?E/\*/8U/YW^'^0?6X?\^X_C_F'_  J70/\
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MX_YA_P *ET#_ )YI_P!^4_PH]C4_G?X?Y!];A_S[C^/^8?\ "I= _P">:?\
M?E/\*/8U/YW^'^0?6X?\^X_C_F'_  J70/\ GFG_ 'Y3_"CV-3^=_A_D'UN'
M_/N/X_YA_P *ET#_ )YI_P!^4_PH]C4_G?X?Y!];A_S[C^/^8?\ "I= _P">
M:?\ ?E/\*/8U/YW^'^0?6X?\^X_C_F'_  J70/\ GFG_ 'Y3_"CV-3^=_A_D
M'UN'_/N/X_YA_P *ET#_ )YI_P!^4_PH]C4_G?X?Y!];A_S[C^/^8?\ "I=
M_P">:?\ ?E/\*/8U/YW^'^0?6X?\^X_C_F'_  J70/\ GFG_ 'Y3_"CV-3^=
M_A_D'UN'_/M?C_F(?A+H&,>6G_?I/\*/8U/YW^'^0OK4'_R[7X_YFI_P@6E?
MW$_[\I_\31[&I_._P_R%]8A_S[7X_P"9UM=1Q!0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 A.!D\"D!3DU?3X3A[N($?[6:I1;V%=(=#JEC<-MBNHF;T#<
MTW&2"Z+6:D8M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % %:]O8;&W:>=L(O'N3Z"A)R8F[&0T%Q? W6HSFUL^HA#;>/]HU
MHG;2)+(DFT5#MM=-:YQP2D.[]33][JP32 OH<S!)[0VDAZ%T,9_,46D)V)U:
M]T4[Y)6N[ _Q?Q1CU]Q2TEH-71M0S1SPK+$X9&&01WJ'H4G<D'2D,* "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@##V'4]<D9R#:
M6G 4]"_K^%:+W8^I-KO4;# VN7+7$YS8(2L</]\C^(^U+X-A6N;4<20H$C0*
MHZ #%3>Y25AEQ:P749CGB5U/8BA-H&KF/#OTN^73YV,UI<<1%^=G^R:NRDKD
MIVT)M-S8ZC<:<21&?WL(]%/4?G1+57".ALUF6% !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 )0 UVVHS>@)H YFWF:'PA<7"G#RLQ)^K
M8K6WO6,[W1T%A$L%C!$HP%0?RK-O4M;%FD,* ,O7T']DR2_QPD2*?0@U<'9D
M3V*EX^=3T:YZ%P5/X@4UI%H75&]FLD:!FB]@#-,!: "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M9*I/2/8ZE4"*JKP , "L+]ST4DE9(?2&% !0 4 % !0 4 % !0 4 % !0 4
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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M=V]@E*VQV-K&8;:*)I&D**%+L<EL#J:S*)J "@ H * "@ H * "@ H * "@
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M;THY7>P>TCR\WZ?IN(=2M1 )BSA2X0@Q-E2>FX8RO;KCK3Y'>P>TCR\WZ/\
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MV4].Q_!J4O=BD)>]*YZ4.#61J+0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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MTX2Y7<)*Z)/!F@GPWX2T[2W $T40,V#D>8>6_4FE.7,[A&-D;XJ2@H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * *%UI[7&J65V' 6W$@*]SN
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MWLU6-DWH)(492&]0=Y_G3<@Y3:M-#NHA<2-:Z3#(\)B6*&WRI!QD,W!(..@
M_&IYAV-#1-/FTW35MYG4L&9@J$E8P3D*I/.!T']*3U&C2I#"@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
, * "@ H * "@#__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
